The Venture Codex Logo

The Venture Codex

ORIX Corporation

2001 Ross Avenue, Suite 1900, Dallas, TX, 75201, United States

Overview

ORIX USA is headquartered in Dallas, Texas, with approximately 1,100 employees and principal offices in Atlanta, Chicago, Los Angeles, Minneapolis, New York, San Francisco, Washington, D.C., Frankfurt, London, and Paris.

Total investments
4
Lead investments
1
Investments · 12mo
0
Active investors
4

Sector focus

  • Financial Services
  • Real Estate
Visit website

Investment portfolio

  • Crusoe Energy Systems

    Participated · Debt Financing · Mar 2025

    Crusoe Energy Systems develops and operates vertically integrated, energy-sourced data centers optimized for artificial-intelligence computing. Its flagship offering, Crusoe Cloud, provides high-performance GPU resources to customers such as Cursor, Decart, Fireworks, Odyssey and Together AI. The company combines rapid energy sourcing, proprietary data-center design, and a managed AI cloud platform to deliver lower-cost and lower-emission compute. To expand service breadth, Crusoe recently acquired Atero, a GPU management and memory-optimization firm, accelerating its managed AI services roadmap. Geographic expansion is underway: the firm is adding capacity in Norway and Iceland and has opened offices in Dublin, Sunnyvale, and Tel Aviv. Major build-outs include a 1.2-gigawatt data-center campus in Abilene, Texas, and a newly announced 1.8-gigawatt campus in Wyoming, with additional multi-gigawatt sites planned across the U.S. Following its latest financing, the company’s valuation is expected to exceed $10 billion, underscoring strong investor confidence in its growth trajectory.

  • Future Family

    Participated · Series B · Apr 2022

    Future Family provides buy-now-pay-later financing for fertility services, offering 60-month loan plans ranging from $300 to $475 per month that cover clinic procedures, lab work and medications. The company partners with clinics to set pricing and eliminate surprise bills. Future Family saw its gross transaction volume — the volume of patients it was financing — jump 300% in 2021 and doubled its headcount that year. Its financing model is positioned against the average IVF cycle cost (around $12,400) to make treatment comparable to other financed purchases. The new funding will be used to expand its clinic network, invest in staffing and product development, and explore new channels. CEO Claire Tomkins indicated more product and growth news is expected in the second half of the year. Future Family partners with fertility clinics to pre-negotiate pricing, eliminate surprise fees, pay bills upfront to clinics, and convert substantial upfront costs into monthly payment plans for patients. Each user is assigned a dedicated Fertility Coach to help navigate the treatment journey. The company was founded out of CEO Claire Tomkins’ own experiences with costly, surprise fertility bills. Future Family saw significant disruption in 2020 when many clinics closed during the pandemic, but reports demand rebounded in 2021 with expectations of record activity in the second half of the year. To meet rising demand, it is expanding its network of partner clinics, adding groups such as CCRM with locations in Minneapolis, Houston, Denver, San Francisco and other metros. Financially, the company is announcing a new $9 million financing as it scales clinic partnerships. Future Family partners with fertility clinics to lock in often unpredictable procedure costs, covers those upfront expenses, and converts them into approachable monthly payment plans for customers. The company covers costs like IVF and egg freezing to make fertility care more accessible. High upfront funding needs produced long waitlists; to address that the company secured a $100 million credit line to serve more people immediately. The new capital is intended to clear waitlists and allow the company to offer same-day approval and financing to new customers. Founder Claire Tomkins started the company after spending hundreds of thousands on fertility care for her first child and aims to simplify and expand access to treatment. Recently Future Family adjusted its model to operate more like a monthly subscription than a loan, allowing additional costs such as genetic testing and travel to be wrapped into financing. This credit facility follows a $10 million Series A raised roughly two months earlier. Future Family offers subscription-based financing for fertility services, shifting from loan-like products to flexible monthly plans that can be adjusted if additional services are needed. Plans start at $195/month for 60 months for clinic pairing and concierge support, while $250/month for 60 months covers lab work, medication, clinic visits and the IVF procedure. The company partners with clinics to pre-negotiate pricing and pays bills upfront to eliminate surprise charges. CEO Claire Tomkins founded the company after personally spending hundreds of thousands on fertility treatments and experiencing unexpected costs. The $10M Series A will be used mainly to expand the monthly subscription offerings and grow the network of partner fertility clinics. The company had previously raised around $4.2M, and Aspect Ventures’ Lauren Kolodny will join Future Family’s board as part of the round.

  • Ridge-i

    Participated · Equity · Jan 2021

    Ridge-i Co., Ltd. announced a ¥780 million funding round executed via a third‑party allotment on January 31, 2021. The transaction included participation from ORIX Corporation, SPARX Group and returning investor Global Brain. The company has raised ¥1,530 million in total funding to date. The round was carried out through a third‑party allotment method. Global Brain is specifically noted as a returning investor in the round. The article does not disclose product details, operating metrics, or future plans.

  • OurCrowd

    Led · Equity · Nov 2020

    OurCrowd operates an online venture investing platform that connects accredited and institutional investors with vetted private technology companies. Founded in 2013 and based in Jerusalem, the platform has built a global investor base of 140,000 accredited investors across more than 195 countries. OurCrowd has invested in over 280 companies and 30 funds, and more than 50 portfolio companies have achieved exits (including Lemonade, Beyond Meat, Uber (Jump), Kenna, Argus and Wave). The company reported rapid user growth, with new subscribers rising from 25,000 in 2020 to 75,000 in 2021 (a 300% increase) with three months still remaining in the year. OurCrowd plans to use new capital to expand the platform, grow its investor base, and accelerate identification of private technology companies. OurCrowd is an Israeli crowdfunding platform that enables accredited and institutional investors to co-invest in startups and provides access to venture funds. The platform has invested in 220 companies across 22 funds and counts exits including Beyond Meat, Lemonade, JUMP Bike, Briefcam and Argus. OurCrowd offers partners access to its startup network and specific portfolio companies. The company plans to collaborate with strategic partners to create financial products and investment opportunities for the Japanese and global markets. Recently it received a $60M strategic investment from ORIX, which the company says will help accelerate its growth and bridge its portfolio to Asian markets. OurCrowd operates an online equity crowdfunding platform that enables accredited investors to co-invest alongside the firm in startups. The company plans to use new capital to expand its seven global offices and further develop its technology platform. Leadership says half of the Series C will be deployed to match investments made on the platform by the General Partner on the same terms as the crowd. OurCrowd has grown to 100 portfolio companies and reports more than $300 million invested across its deals, with nine exits (two IPOs and seven acquisitions). The firm is based in Israel and has signaled an ambition to scale its annual investment target to $1 billion by 2020. OurCrowd operates a hybrid venture-capital and equity crowdfunding platform that selects opportunities, invests its own capital, and offers curated deals to accredited members. The platform requires accredited investors to invest a minimum of $10,000 per deal and provides post-investment support, including mentors and board seats. Since launching in February 2013, OurCrowd has built a community of about 4,000 accredited investors and assembled 36 portfolio companies. To date the platform has raised $43 million for its portfolio companies across deals in 26 countries, with individual portfolio rounds growing to over $3 million and 18 companies having raised more than $1 million each. OurCrowd recently closed a $25 million Series B, which the company says is the largest round in the equity crowdfunding sector to date. The company plans to use the proceeds to expand activities in Israel and worldwide and to provide general partner funding participation for each OurCrowd deal.

Team